Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 14:6:314.
doi: 10.3389/fphar.2015.00314. eCollection 2015.

Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison

Affiliations
Review

Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison

Gildas Loussouarn et al. Front Pharmacol. .

Abstract

Mutations in Nav1.4 and Nav1.5 α-subunits have been associated with muscular and cardiac channelopathies, respectively. Despite intense research on the structure and function of these channels, a lot of information is still missing to delineate the various physiological and pathophysiological processes underlying their activity at the molecular level. Nav1.4 and Nav1.5 sequences are similar, suggesting structural and functional homologies between the two orthologous channels. This also suggests that any characteristics described for one channel subunit may shed light on the properties of the counterpart channel subunit. In this review article, after a brief clinical description of the muscular and cardiac channelopathies related to Nav1.4 and Nav1.5 mutations, respectively, we compare the knowledge accumulated in different aspects of the expression and function of Nav1.4 and Nav1.5 α-subunits: the regulation of the two encoding genes (SCN4A and SCN5A), the associated/regulatory proteins and at last, the functional effect of the same missense mutations detected in Nav1.4 and Nav1.5. First, it appears that more is known on Nav1.5 expression and accessory proteins. Because of the high homologies of Nav1.5 binding sites and equivalent Nav1.4 sites, Nav1.5-related results may guide future investigations on Nav1.4. Second, the analysis of the same missense mutations in Nav1.4 and Nav1.5 revealed intriguing similarities regarding their effects on membrane excitability and alteration in channel biophysics. We believe that such comparison may bring new cues to the physiopathology of cardiac and muscular diseases.

Keywords: Nav1.4; Nav1.5; associated/regulatory proteins; missense mutations; physiopathology.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Schematic representation of the localization of the binding sites of associated/regulatory proteins identified for Nav1.4 (blue), Nav1.5 (pink), or both (purple). Nav1.4 interaction with ankyrin is only suggested by chimeric constructs, it remains to be studied with full length proteins (Lemaillet et al., 2003). DI to DIV, domains I to IV; ID, intracellular interdomains; N-ter and C-ter, N-and C-terminus ends. (B) Table presenting the amino-acid (aa) numbering and length of specific regions and domains in Nav1.4 and Nav1.5 proteins. It is noticeable that Nav1.4 IDI-II total amino-acid length is shorter than Nav1.5 IDI-II.
Figure 2
Figure 2
Schematic representation of the equivalent Nav1.4/Nav1.5 amino acids with similar (A) or divergent (B) mutations in patients with skeletal (Nav1.4) or cardiac (Nav1.5) pathologies. Upward triangles indicate a gain of function on membrane excitability and downward triangles a loss of function on membrane excitability. Green and red triangles indicate consistent and inconsistent effects on Nav1.4 and Nav1.5 regarding membrane excitability, respectively. Upper amino acid number/letter, Nav1.4; Lower amino acid number/letter, Nav1.5. DI to DIV, domains I to IV; ID, intracellular interdomains; N-ter and C-ter, N-and C-terminus ends.

Similar articles

Cited by

References

    1. Abriel H. (2010). Cardiac sodium channel Na(v)1.5 and interacting proteins: physiology and pathophysiology. J. Mol. Cell. Cardiol. 48, 2–11. 10.1016/j.yjmcc.2009.08.025 - DOI - PubMed
    1. Ackerman M. J., Priori S. G., Willems S., Berul C., Brugada R., Calkins H., et al. . (2011). HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 8, 1308–1339. 10.1016/j.hrthm.2011.05.020 - DOI - PubMed
    1. Ackerman M. J., Siu B. L., Sturner W. Q., Tester D. J., Valdivia C. R., Makielski J. C., et al. . (2001). Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 286, 2264–2269. 10.1001/jama.286.18.2264 - DOI - PubMed
    1. Aiba T., Farinelli F., Kostecki G., Hesketh G. G., Edwards D., Biswas S., et al. . (2014). A mutation causing Brugada syndrome identifies a mechanism for altered autonomic and oxidant regulation of cardiac sodium currents. Circ. Cardiovasc. Genet. 7, 249–256. 10.1161/CIRCGENETICS.113.000480 - DOI - PMC - PubMed
    1. Allouis M., Le Bouffant F., Wilders R., Péroz D., Schott J. J., Noireaud J., et al. . (2006). 14-3-3 is a regulator of the cardiac voltage-gated sodium channel Nav1.5. Circ. Res. 98, 1538–1546. 10.1161/01.RES.0000229244.97497.2c - DOI - PubMed